Hiroshi Ishimoto

Nagasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 154 publications

HLA-DRB3/4/5-based susceptibility profiles in nivolumab-induced type 1 diabetes and interstitial lung disease.

HLA-DRB3/4/5-based susceptibility profiles in nivolumab-induced type 1 diabetes and interstitial lung disease.

Journal: Frontiers in immunology

Published: March 27, 2026

Marine-derived surfactin derivatives suppress collagen production and interfere with the HSP47-collagen interaction in preclinical models.

Marine-derived surfactin derivatives suppress collagen production and interfere with the HSP47-collagen interaction in preclinical models.

Journal: Frontiers in pharmacology

Published: February 11, 2026

CARE: a next-generation high resolution cloud and radiation remote sensing product and its Earth system applications.

CARE: a next-generation high resolution cloud and radiation remote sensing product and its Earth system applications.

Journal: Science bulletin

Published: November 09, 2025

Pulmonary fibrosis with a rare SFTPC variant (c.304G>A, p.Val102Met): A case report.

Pulmonary fibrosis with a rare SFTPC variant (c.304G>A, p.Val102Met): A case report.

Journal: Respiratory investigation

Published: November 06, 2025

Response to Letter to the Editor: Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis From a Multicenter Observational Study in Kyushu and Okinawa, Japan.

Response to Letter to the Editor: Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis From a Multicenter Observational Study in Kyushu and Okinawa, Japan.

Journal: Clinical therapeutics

Published: October 09, 2025

Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitor.

Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitor.

Journal: Discover oncology

Published: August 21, 2025

Efficacy of Lactococcus lactis Strain Plasma in Patients with Mild COVID-19: A Multicenter, Double-Blinded, Randomized-Controlled Trial (PLATEAU Study).

Efficacy of Lactococcus lactis Strain Plasma in Patients with Mild COVID-19: A Multicenter, Double-Blinded, Randomized-Controlled Trial (PLATEAU Study).

Journal: Infectious diseases and therapy

Published: August 17, 2025

Microplastics in Human Bronchoalveolar Lavage Fluid.

Microplastics in Human Bronchoalveolar Lavage Fluid.

Journal: Respirology (Carlton, Vic.)

Published: January 26, 2025

A case of humidifier lung potentially caused by Cryptococcuslaurentii.

A case of humidifier lung potentially caused by Cryptococcuslaurentii.

Journal: Respiratory investigation

Published: January 21, 2025

Primary ciliary dyskinesia in a Japanese woman caused by a novel RSPH4A variant.

Primary ciliary dyskinesia in a Japanese woman caused by a novel RSPH4A variant.

Journal: Respiratory investigation

Published: January 15, 2025

Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia.

Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia.

Journal: Journal of autoimmunity

Published: January 03, 2025

Molecular analysis of bronchoalveolar lavage fluid to assist pulmonary lymphoma diagnoses.

Molecular analysis of bronchoalveolar lavage fluid to assist pulmonary lymphoma diagnoses.

Journal: ERJ open research

Published: December 20, 2024

Showing 1-12 of 154

Last Updated: 09/26/2026